首页 | 本学科首页   官方微博 | 高级检索  
检索        

论药品可及性与药品专利保护
引用本文:刘莹,梁毅.论药品可及性与药品专利保护[J].中国药房,2007,18(13):966-968.
作者姓名:刘莹  梁毅
作者单位:中国药科大学国际医药商学院,南京市,210009
摘    要:目的:寻找保护我国目前创新能力尚未成熟的民族制药业的途径,并确保药品可及性。方法:利用需求弹性理论、健康权与专利权属性比较等方法,结合TRIPS协议和国外的相关实践进行分析。结果与结论:对于我国这样的发展中国家来说,首先应当优先考虑眼前急迫的需要,如满足人民群众用药需求;然后逐步满足长远的需要,如鼓励自主知识产权,因此应有步骤地完善药品专利制度中与药品可及性相关的制度。

关 键 词:药品可及性  药品专利  健康权  保护
文章编号:1001-0408(2007)13-0966-03
修稿时间:2006年6月21日

On Accessibility and Patent Protection of Drugs
LIU Ying,LIANG Yi.On Accessibility and Patent Protection of Drugs[J].China Pharmacy,2007,18(13):966-968.
Authors:LIU Ying  LIANG Yi
Abstract:OBJECTIVE: To seek approach for the protection of domestic pharmaceutical enterprises with immature creativity and to ensure drug accessibility. METHODS: An analysis was performed applying the theory of demand elasticity by comparing the attributes of health right and patent right etc based on TRIPS protocol and the related practice abroad. RESULTS & CONCLUSIONS: For a developing country, China should give top priority to the short-term urgent needs, such as to meet people's medication demands, followed by meeting the long-term demands, such as to encourage independent intellectual property rights. Hence, drug accessibility-related system in drug patent system should be evolved step by step.
Keywords:Drug accessibility  Drug patent  Right of health  Protection
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号